Showing results (511-520 of 611) with videos related to

Sort By:
Pageof 62
Antimicrobial Agents and Chemotherapy|March 9, 2011
Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin familyMatthew A Gregory, Michael Bobardt, Susan Obeid, et al.
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
ACS Infectious Diseases|February 7, 2018
Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-onesAsier Gómez-SanJuan, Ana-María Gamo, Leen Delang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2022
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunitySean McCafferty, A K M Ashiqul Haque, Aster Vandierendonck, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Structural Insights into the Mechanisms of Action of Functionally Distinct Classes of Chikungunya Virus Nonstructural Protein 1 InhibitorsKristina Kovacikova, Marina Gorostiola González, Rhian Jones, et al.
Nature Communications|November 5, 2022
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamstersSapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, et al.
Antiviral Research|February 19, 2024
Mechanism of action of phthalazinone derivatives against rabies virusVictoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, et al.
Nature Genetics|March 9, 2021
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2Jim Baggen, Leentje Persoons, Els Vanstreels, et al.
Plos One|June 22, 2012
The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase functionChristy M Hebner, Bin Han, Katherine M Brendza, et al.
Journal of Virology|February 2, 2022
Restriction of Viral Replication, Rather than T Cell Immunopathology, Drives Lethality in Murine Norovirus CR6-Infected STAT1-Deficient MiceAndrew J Sharon, Heather A Filyk, Nicolette M Fonseca, et al.
Pageof 62